...
首页> 外文期刊>Oncology letters >Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center
【24h】

Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center

机译:手术可转移胰腺神经内分泌肿瘤的长期结果的预后因素:单个中心的12年经验

获取原文
获取原文并翻译 | 示例

摘要

The present study was performed to assess the prognostic factors with respect to patient survival and clinicopathological characteristics for patients who underwent surgery for pancreatic neuroendocrine tumors (PNETs). A retrospective review of patients pathologically diagnosed with PNETs at the First Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou, Zhejiang, China) between September 2002 and September 2013 was conducted. The clinicopathological findings, overall survival (OS) rate and disease-free survival (DFS) rate of the patients with PNETs were analyzed. Prognostic factors were determined by univariate and multivariate analyses. A total of 104 patients were selected. The median age at presentation was 52 years (range, 19-76 years). The most common surgical procedure was distal pancreatectomy (51.0%), followed by pancreaticoduodenectomy (27.9%) and local resection of the pancreas (16.3%). The majority of the tumors were of low or moderate grade (93.3%, grade 1 or 2) and were local or regional stage (92.3%). The 1-, 3-and 5-year OS rates were 95, 85 and 73%, respectively. Meanwhile, the 1-, 3-and 5-year DFS rates were 86, 72 and 68%, respectively. The OS and DFS rates were significantly different with regard to the grade (grades 1, 2 and 3; P< 0.001) and stage (local, regional and distant disease; P<0.001). Furthermore, patients with a low Ki-67 index experienced superior OS and DFS rates compared with patients with a high Ki-67 index (P<0.001). The presence of lymph node metastasis was predictive of inferior OS and DFS rates compared with the absence of lymph node metastasis (P<0.001). OS rate for PNETs was significantly affected by resection margin status (P<0.001). In multivariable analysis, the significant factors associated with OS rate were stage (P= 0.02), grade (P< 0.001), lymph node status (P=0.025), Ki-67 index (P=0.031) and resection margin status (P< 0.001). Meanwhile, stage (P=0.001), grade (P=0.017), lymph node status (P=0.02) and Ki-67 index (P=0.016) were prognostic factors for DFS rate. In conclusion, grade, stage, Ki-67 index and lymph node involvement are significant prognostic factors for OS and DFS rates in surgically resectable PNETs. Furthermore, surgical margin status may also be an independent predictor for the prognosis of PNETs. It is anticipated that these findings may provide useful predictors of clinical survival, particularly in the setting of resected disease.
机译:进行本研究以评估关于患者存活率和临床病理特征的预后因素,对胰腺神经内分泌肿瘤(PNets)进行手术的患者。对浙江大学医学院第一次附属医院(杭州,中国)于2002年至2013年9月至2013年9月,进行了对病理上诊断的患者的回顾性审查。分析了PNET患者的临床病理发现,总体存活率和无病生存率(DFS)率。预后因子由单变量和多变量分析确定。共选出104名患者。演示文稿的中位年龄为52年(范围,19-76岁)。最常见的外科手术是远端胰腺切除术(51.0%),其次是胰腺癌切除术(27.9%)和胰腺局部切除(16.3%)。大多数肿瘤低于或中等级(93.3%,1或2级),是局部或区域阶段(92.3%)。 1-,3年和5年的OS率分别为95,85和73%。同时,1-,3和5年的DFS率分别为86,72和68%。关于等级(1,2和3级; P <0.001)和阶段(局部,区域和远处疾病; P <0.001)显着不同。此外,与高ki-67指数的患者相比,患有低KI-67指数的患者经历了优异的OS和DFS率(P <0.001)。与没有淋巴结转移的情况相比,淋巴结转移的存在预测性较差的OS和DFS速率(P <0.001)。 PNets的OS率受切除边缘状态的显着影响(P <0.001)。在多变量分析中,与OS率相关的重要因素是阶段(p = 0.02),等级(p <0.001),淋巴结状态(p = 0.025),ki-67指数(p = 0.031)和切除裕度状态(p <0.001)。同时,阶段(P = 0.001),等级(P = 0.017),淋巴结状态(P = 0.02)和KI-67指数(P = 0.016)是DFS率的预后因素。总之,等级,阶段,ki-67指数和淋巴结受累是术后动态可重置PNET中的OS和DFS率的显着预后因素。此外,手术边缘状态也可能是PNets预后的独立预测因子。预计这些发现可以提供临床生存的有用预测因子,特别是在切除疾病的环境中。

著录项

  • 来源
    《Oncology letters 》 |2017年第1期| 共8页
  • 作者单位

    Zhejiang Univ Div Hepatobiliary &

    Pancreat Surg Dept Surg Sch Med Affiliated Hosp 1 79 Qingchun;

    Zhejiang Univ Div Hepatobiliary &

    Pancreat Surg Dept Surg Sch Med Affiliated Hosp 1 79 Qingchun;

    Zhejiang Univ Div Hepatobiliary &

    Pancreat Surg Dept Surg Sch Med Affiliated Hosp 1 79 Qingchun;

    Zhejiang Univ Div Hepatobiliary &

    Pancreat Surg Dept Surg Sch Med Affiliated Hosp 1 79 Qingchun;

    Zhejiang Univ Div Hepatobiliary &

    Pancreat Surg Dept Surg Sch Med Affiliated Hosp 1 79 Qingchun;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号